← Back to Influence Map
Entity DossierOrganization
EISAI, INC.
DC · US
human health care company
fara
Tracked direct giving
$0
LDA reported lobbying spend
$6,210,000
Connections
5
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
MMMMedicare/Medicaid
$9.6MHCRHealth Issues
$8.6MTAXTaxation/Internal Revenue Code
$7.0MTRDTrade
$4.0MBUDBudget/Appropriations
$2.6MCPTCopyright/Patent/Trademark
$1.3MMANManufacturing
$1.3MPHAPharmacy
$270KDEFDefense
$200KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$7.9M
ROBERTI ASSOCIATES CONSULTING, LLC$700K
CROSSROADS STRATEGIES, LLC$690K
RICCHETTI INCORPORATED$270K
Bills Referenced in Lobbying Filings
PBM
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | CROSSROADS STRATEGIES, LLC | Hired CROSSROADS STRATEGIES, LLC to lobby on Pharmaceuticals | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $50,000 | Source |
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2025-1889: Global Benchmark for Efficient Drug Pricing Model | Source |
| Retained | ROBERTI ASSOCIATES CONSULTING, LLC | Hired ROBERTI ASSOCIATES CONSULTING, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | RICCHETTI INCORPORATED | Hired RICCHETTI INCORPORATED to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |